WHAT RESEARCHERS STUDY
Primary research interest.
- Anxiety and stress-response measures
- GABA-related signalling hypotheses
- Learning and memory models
- Cytokine and immune-signalling research
NEW
STRESS RESPONSE RESEARCH · IP-SELANK-10
Selank
Stress-response, anxiety and neuropeptide signalling research.
EVIDENCE SNAPSHOT · Small regional human studies and preclinical data
Selank is a synthetic heptapeptide derived from tuftsin. Published research has examined anxiety-related outcomes, learning and immune-signalling mechanisms.
10 mg / vial$75.00 CAD
FOR LABORATORY RESEARCH USE ONLYNot for human or animal consumption. No dosing or administration information is provided.
COMMUNITY DISCUSSION · ANECDOTAL
What people discuss online.
Online users commonly describe calmness, reduced social anxiety and “clear focus” without sedation, while others report little effect. These are personal accounts rather than controlled evidence.
Community reports can be affected by placebo effects, concurrent products, training, diet, selection bias and inaccurate product identity.
EVIDENCE LIMITS
What the page does not claim.
Available human studies are small and largely regional. Selank is not approved by Health Canada or the FDA for anxiety treatment or cognitive enhancement.
SOURCES & FURTHER READING
Review the evidence directly.
Small comparative anxiety study — PubMed ↗Molecular review — PubMed ↗Community discussion — Reddit ↗Related catalog materials
View full catalog →
